Terms: = Ovarian cancer AND MDM4, DKFZp781B1423, 4194, ENSG00000198625, RP11-430C7_1, MRP1, MDMX, MGC132766 AND Staging
1272 results:
1. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
[TBL] [Abstract] [Full Text] [Related]
2. Outcomes after fertility-sparing surgery of early-stage ovarian cancer: A nationwide population-based study.
Lee CY; Chiang CJ; Tai YJ; Hsu HC; Chen YL; Chiang YC; Wu CY; Lee WC; Hwa HL; Cheng WF
Cancer Med; 2024 Apr; 13(7):e7132. PubMed ID: 38606892
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
4. The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.
Li N; Chen Q; Li B
Medicine (Baltimore); 2024 Mar; 103(11):e37465. PubMed ID: 38489719
[TBL] [Abstract] [Full Text] [Related]
5. The Role of Lymphovascular Space Invasion and Cytology in the Prognosis of Endometrial cancer.
Ozdemir CY; Arioz DT; Celik F; Cicekli N; Chkhikvadze M; Bilir F; Yılmaz S; Vatansever N
Discov Med; 2024 Feb; 36(181):366-371. PubMed ID: 38409841
[TBL] [Abstract] [Full Text] [Related]
6. Laparoscopic versus laparotomic surgical treatment in apparent stage I ovarian cancer: a multi-center retrospective cohort study.
Zhang J; Li M; Feng L; Zhai Y; Wang L; Chen Y
World J Surg Oncol; 2024 Feb; 22(1):62. PubMed ID: 38389046
[TBL] [Abstract] [Full Text] [Related]
7. The significance of lower uterine segment involvement in endometrial cancer.
Davidesko S; Meirovitz M; Shaco-Levy R; Yarza S; Samueli B; Kezerle Y; Kessous R
Eur J Surg Oncol; 2024 Mar; 50(3):108007. PubMed ID: 38382274
[TBL] [Abstract] [Full Text] [Related]
8. Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer.
Gravbrot N; Weil CR; DeCesaris CM; Gaffney DK; Suneja G; Burt LM
Eur J Cancer; 2024 Apr; 201():113913. PubMed ID: 38377777
[TBL] [Abstract] [Full Text] [Related]
9. To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma.
Yadav A; Sistla A; Swain M; Gowrishankar S; Padua M; Modi T; Himabindu R; Agarwal N; Kulkarni A; Bhandari T; Vudayaraju H; Chinnababu ; Reddy VA
Indian J Pathol Microbiol; 2024; 67(1):62-67. PubMed ID: 38358190
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria.
Ajani MA; Lawan A; Oke T; Khramtsova G; Nwanji I; Salami A; Awolude O; Ebili H; Onwukamuche ME; Sveen E; Yoshimatsu T; Olopade OI
Afr Health Sci; 2023 Sep; 23(3):236-244. PubMed ID: 38357171
[TBL] [Abstract] [Full Text] [Related]
11. Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review.
Khessib T; Jha P; Davidzon GA; Iagaru A; Shah J
Semin Nucl Med; 2024 Mar; 54(2):270-292. PubMed ID: 38342655
[TBL] [Abstract] [Full Text] [Related]
12. Metabolic-Related Gene Prognostic Index for Predicting Prognosis, Immunotherapy Response, and Candidate Drugs in ovarian cancer.
Guo S; Liu Y; Sun Y; Zhou H; Gao Y; Wang P; Zhi H; Zhang Y; Gan J; Ning S
J Chem Inf Model; 2024 Feb; 64(3):1066-1080. PubMed ID: 38238993
[TBL] [Abstract] [Full Text] [Related]
13. Is routine gastrointestinal endoscopy required in every woman with mucinous ovarian cancer? An analysis of survival rates and metastatic tumours in a cancer centre.
Katsanevakis E; Addo-Yobo W; Bharathan B; Loona A; Gan C; Nunns D; Gajjar K
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():105-110. PubMed ID: 38237307
[TBL] [Abstract] [Full Text] [Related]
14. Survival outcomes of epithelial ovarian cancer treated at a tertiary-level hospital in India.
Chandy RG; Thomas V; Sebastian A; Mani T; Thomas A; Joel A; Ram TS; Peedicayil A
Indian J Cancer; 2023 Oct; 60(4):475-485. PubMed ID: 38185864
[TBL] [Abstract] [Full Text] [Related]
15. Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs.
Vasta FM; Cormio G; Cassani C; Bergamini A; Scarfone G; Ferrandina G; De Vivo R; Marinaccio M; Danese S; Raspagliesi F; Pignata S; Mangili G
Gynecol Oncol; 2024 Feb; 181():28-32. PubMed ID: 38104526
[TBL] [Abstract] [Full Text] [Related]
16. Critical elements in the operative management of pediatric malignant ovarian germ cell tumors.
Weil BR; Rich BS; Madenci AL; Stambough KC; Schmoke N; Peace A; Bruny JL; Rescorla FJ; Dicken BJ; Dietrich JE; Billmire DF
Semin Pediatr Surg; 2023 Oct; 32(5):151342. PubMed ID: 38039829
[TBL] [Abstract] [Full Text] [Related]
17. Effects of epidural anesthesia on the prognosis of ovarian cancer-a systematic review and meta-analysis.
Shen H; Pang Q; Gao Y; Liu H
BMC Anesthesiol; 2023 Nov; 23(1):390. PubMed ID: 38030996
[TBL] [Abstract] [Full Text] [Related]
18. Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY).
Nero C; Bizzarri N; Di Berardino S; Sillano F; Vizzielli G; Cosentino F; Vargiu V; De Iaco P; Perrone AM; Vizza E; Chiofalo B; Uccella S; Ghezzi F; Turco LC; Corrado G; Giannarelli D; Pasciuto T; Zannoni GF; Fagotti A; Scambia G
Eur J Cancer; 2024 Jan; 196():113435. PubMed ID: 38006759
[TBL] [Abstract] [Full Text] [Related]
19. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
Lim YH; Dagher C; Abu-Rustum NR; Mueller JJ; Sonoda Y; Zivanovic O; Broach V; Leitao MM
Gynecol Oncol; 2023 Dec; 179():152-157. PubMed ID: 37980770
[TBL] [Abstract] [Full Text] [Related]
20. Mapping sentinel lymph nodes in early-stage ovarian cancer (MELISA) trial - a further step towards lymphadenectomy replacement.
Agustí N; Vidal-Sicart S; Paredes P; Celada-Castro C; Migliorelli F; Glickman A; Marina T; Fusté P; Carreras-Dieguez N; Saco A; Díaz-Feijóo B; Torné A
Gynecol Oncol; 2023 Dec; 179():145-151. PubMed ID: 37980769
[TBL] [Abstract] [Full Text] [Related]
[Next]
